The FDA's streamlined biosimilar approval process aims to foster a competitive marketplace, potentially reducing insulin prices in the US. Merilog (insulin-aspart-szjj) is the first rapid-acting ...

Under the terms of the agreement, Biocon Biologics will supply Insulin Aspart drug substance to Civica, who will use the drug substance to produce Insulin Aspart drug product, a rapid-acting ...

WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently approved Merilog (insulin-aspart-szjj) as the first rapid-acting insulin biosimilar to Novolog (insulin aspart).

Lumjev or faster aspart [iASP] do not provide a rapid onset of action. The only insulin that has a rapid on and off effect is TI-Afrezza insulin. The current study by Beck et al. supports ...

Learn everything you need to know about Insulin Aspart-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions ...

An investigational-device exemption was approved by the Food and Drug Administration (FDA ... but did not have approval authority. The insulin aspart that was used in the trial was provided ...